Schrodinger, Inc. (SDGR) stock

SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3079% above fair value

$30.85−0.67 (-2.13%)

Close on Nov 12, 2026Market cap $2.31BP/E –Yield –

Schrodinger EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Schrodinger's EPS for the twelve months ending Sep 30, 2026 was -$0.79. For fiscal 2025 it was -$1.41. The highest annual figure on record is $0.54 in fiscal 2023.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$1.41	–
FY2024	Dec 31, 2024	-$2.57	-575.9%
FY2023	Dec 31, 2023	$0.54	–
FY2022	Dec 31, 2022	-$2.10	–
FY2021	Dec 31, 2021	-$1.42	–
FY2020	Dec 31, 2020	-$0.41	–
FY2019	Dec 31, 2019	-$4.09	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	-$0.50	–
Q2 FY2026	Jun 30, 2026	$0.08	–
Q1 FY2026	Mar 31, 2026	-$0.81	–
Q4 FY2025	Dec 31, 2025	$0.44	–
Q3 FY2025	Sep 30, 2025	-$0.45	–
Q2 FY2025	Jun 30, 2025	-$0.59	–
Q1 FY2025	Mar 31, 2025	-$0.82	–
Q4 FY2024	Dec 31, 2024	-$0.55	–
Q3 FY2024	Sep 30, 2024	-$0.52	–
Q2 FY2024	Jun 30, 2024	-$0.74	-1333.3%
Q1 FY2024	Mar 31, 2024	-$0.76	-143.4%
Q4 FY2023	Dec 31, 2023	-$0.41	–
Q3 FY2023	Sep 30, 2023	-$0.86	–
Q2 FY2023	Jun 30, 2023	$0.06	–
Q1 FY2023	Mar 31, 2023	$1.75	–
Q4 FY2022	Dec 31, 2022	-$0.38	–
Q3 FY2022	Sep 30, 2022	-$0.56	–
Q2 FY2022	Jun 30, 2022	-$0.67	–
Q1 FY2022	Mar 31, 2022	-$0.48	–
Q4 FY2021	Dec 31, 2021	-$0.43	–
Q3 FY2021	Sep 30, 2021	-$0.49	-1080.0%
Q2 FY2021	Jun 30, 2021	-$0.49	–
Q1 FY2021	Mar 31, 2021	$0.00	–
Q4 FY2020	Dec 31, 2020	-$0.16	–
Q3 FY2020	Sep 30, 2020	$0.05	–
Q2 FY2020	Jun 30, 2020	-$0.05	–
Q1 FY2020	Mar 31, 2020	-$0.34	–
Q3 FY2019	Sep 30, 2019	-$0.26	–
Q2 FY2019	Jun 30, 2019	-$0.01	–
Q1 FY2019	Mar 31, 2019	-$0.98	–